Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MNI (immuno pharm) > L25- Antibacterial Therapy I, background > Flashcards

L25- Antibacterial Therapy I, background Flashcards

1
Q

list the different ways Antibacterials can be classified

A
  • MOA
  • spectrum of activity
  • clinical uses
  • selective toxicity / AEs
  • contraindications
  • mechanism of resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define the following:

  • (1) antimicrobial
  • (2) antibacterial
  • (3) antibiotic
A

1- inhibits growth of micro-organisms

2- inhibits growth of bacteria

3- inhibits growth of micro-organisms- made by other micro-organisms [but now its extended to include synthetic drugs]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

list the main MOAs of antibacterials

A
  • cell wall synthesis
  • protein synthesis inhibitors
  • drugs affecting nucelic acid synthesis
  • urinary antiseptics
  • Misc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

compare and contrast the effect and use of antibacterials that are Bacteriostatic and Bacteriocidal

A

Static:

  • reversible inhibition of growth - growth returns once drug is removed, does not dec bacterial numbers
  • used in immunocompetent patients –> immune system recovers and prepares for microbial removal
  • used in minor infections

Cidal:

  • irreversible inhibition of growth - destroys present bacteria
  • used in immunocompromised patients
  • used in life-threatening infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

define Selective Toxicity, include the two main mechanisms to achieve it

A

Defn: ability to injure/kill an invading micro-organism w/o harming host

i) ideally target sites unique to infecting organism (sites not in host): eg. cell walls / peptidoglycan
ii) alternatively target sites different to the host equivalent: eg. prokaryotic v eukaryotic ribosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

define Postantibiotic effect and some of the mechanism that cause this effect

A

Defn: killing action of drug continues once plasma levels are below measurable

  • lag time: if irreversible enzyme inhibitors – time it takes to synthesize new proteins
  • persistence of agent in target site (outside of plasma)
  • enhanced susceptibility of bacteria to phagocytosis or other defense mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

list the antibacterial spectums

A

Broad
Narrow
Extended (in between)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Broad Spectrum antibacterials:

  • (1) uses
  • (2) disadvantages
A

1- empiric therapy, mixed infections

2:

  • selection for MDR bacteria (resistant)
  • disruption of normal flora
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Narrow Spectrum antibacterials:

  • (1) uses
  • (2) disadvantages
A

1- treats infections of known origin (requires culture)

2- must know causal agent, not useful for empiric treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Extended Spectrum antibacterials:

  • (1) uses
  • (2) disadvantages
A

1- empiric therapy, mixed infections

2:

  • selection for MDR bacteria (resistant)
  • disruption of normal flora
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define MIC and MBC

A

MIC- minimum inhibitory concentration, lowest [antibiotic] that prevents VISIBLE growth

MBC- minimum bactericidal concentration, lowest [antibiotic] that yields 99.9% decline in colony count

Note- MBC is slightly greater than MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe how MIC and MBC are determined

A

Dilution Method

1) MIC: serial dilutions of antibiotic, MIC = the tube with least [antibiotic] w/o visible growth
2) MBC: dilutions + agar, use all the dilutions and place on agar to culture, MBC = dilution area w/o colony formation

Disk Sensitivity Test- MIC only
-place antibacterial disks of differing concentrations of growth plate with bacteria –> MIC = lowest concentration with clear zone around disk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

list the factors to consider when selecting Antibacterials

A
  • organism identity
  • organism susceptibility to an agent
  • necessity of empiric therapy (out-patient)
  • site of infection
  • pharmacological factors
  • patient factors
  • cost of therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

______ is the best test / most common test for identifying organisms in bacterial infections since cultures can take too long, include:

  • structural difference
  • test result differences
  • Tx differences
A

Gram Stain
Pos:
-thick-mesh like cell wall made of peptidoglycan
-purple on microscopy
-easier for antibacterials to traverse cell wall

Neg:

  • narrow cell wall, outer membrane
  • pink on microscopy
  • hard for antibacterials to enter organism, must utilize porin system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe how antibiotics enhance bacterial resistance

A

1) initial infectious population has rare resistant bacteria
2) antibiotic given –> kills non-resistant bacteria
3) resistant bacteria multiply => infection that is more difficult to treat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe the mechanisms of resistance to antibiotics (hint- 3)

A
  • altered antibiotic uptake: dec permeability, dec uptake mechanisms, or inc in multi-drug resistant pumps
  • altered target: change in receptor structure and drug affinity or modification of targeted metabolic pathway
  • drug inactivation: eg. bacterial enzymes altering and inactivating drug
17
Q

define primary and acquired drug resistance

A

Primary (no target): structural absence of target for drug to act on; eg. mycoplasma lack cell wall => penicillin resistance

Acquired (genetic changes):

  • spontaneous DNA mutations
  • DNA transfer of drug resistance (plasmid)
  • altered expression of proteins in drug-resistant organisms (epigenetics)
18
Q

(1) therapy is either initiated in patients with minor infections or (2) situations. Selection of (1) therapy is influenced by (3) and (4). (5) is often the initial type of therapy used in (1) therapy.

A

1- empirical therapy
2- urgency or immediate therapy is required and cultures are too slow, eg. meningitis

3- site of infection
4- Pt Hx: HA or CA infections

5- broad spectrum therapy

19
Q

what are the drug qualities that determine its ability to penetrate BBB

A
  • lipid solubility (inc –> more able to diffuse across BBB)
  • MW (smaller the better)
  • protein binding of drug (low affinity for plasma proteins better, higher affinity for transport proteins better)
20
Q

list the many pharmacological factors that influence drug selection

A
  • route of administration
  • route of elimination (liver, kidney- eg. UTI agents must be eliminated thru renal system)
  • 1/2 life affected by disease or other drugs (contraindications)
  • drug interactions
  • dosing schedule (out-patient, not an issue for in-patient)
  • AEs and idiosyncratic responses
21
Q

oral administration of antibacterials is preferred in (1) situations

parenteral administration is preferred in (2) situations

A

1- mild infections

2- serious infections, or if oral bioavailability via GIT is poor

22
Q

list the common complications of antibiotic therapy

A
  • Hypersensitivity: frequently, ranges from urticaria –> anaphylaxis
  • Direct toxicity: directly affects host cellular processes
  • Superinfection: new or secondary infection during therapy of initial / primary infection
23
Q

what are the patient factors to consider when selecting antibacterials

A
  • immune system status (competent, compromised)
  • renal and or hepatic dysfunction
  • poor perfusion
  • age
  • pregnancy, lactation
24
Q

list the advantages of combination antibacterial therapy

A
  • achieves synergistic effects
  • good in emergency situations
  • delays resistance
  • treats mixed infections
  • treats immunocompromised / immunosuppressed
25
Q

what are the mechanisms of synergistic effects among antibacterials

A
  • Sequential blockade in pathways (eg. Sulfamethoxazole + Trimethoprim)
  • Blockade of drug-inactivating enzymes (eg. Augmentin = clavulanic acid + amoxicillin)

Enhanced drug uptake

26
Q

list the disadvantages of combination antibacterial therapy

A
  • some agents only work on multiplying/dividing bacteria –> so if one agent causes baceteriostasis than the other may be less effective (eg. β-lactams + tetracyclines)
  • may select for MDR bacteria
27
Q

list some of the guidelines for antimicrobial chemoprophylaxis

A
  • always directed towards specific pathogen (narrow spectrum)
  • no development of resistance
  • limited duration of use
  • conventional therapeutic doses should be used
  • only in situations with proven drug efficacy
28
Q

list some non-surgical situations when antimicrobial chemoprophylaxis may be employed

A
  • prevention of CMV, HIV, influenza, meningococcal infections, TB
  • animal or human bite
  • chronic bronchitis
29
Q

describe the use of antimicrobial chemoprophylaxis in terms of surgical prophylaxis

A

limited to procedures where infections occur in >50% of untreated cases under optimal conditions

eg. GI procedures, vaginal hysterectomy, C-section, joint replacement, open fracture surgery

MNI (immuno pharm) (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions